Delivery Order SPE2DB24D8001-SPE2DB25FKZPP
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DB24D8001 and SPE2DB25FKZQN, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and is part of the DLA Troop Support Medical's ECAT...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
The federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical under the ECAT Generation V Program. The firm fixed-price delivery order, valued at $1,291.82, is for the supply of the prescription drug Trulicity (1.5 mg/0.5 ml pen) with an ultimate completion date of August 22, 2024. This contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with...
This contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,505.02 Firm Fixed Price Delivery Order contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and runs through December 31, 2025. It is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNU, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including items such as Trulicity, Mounjaro, Entresto, Stelara, Dupixent, and various vaccines. The contract is an Indefinite Delivery Contract (IDC) that is part of the DLA Troop...
This federal contract award, valued at $2,032.02, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The contract requires the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. Armed Forces medical operations. This award is not set-aside and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, valued at $2,638.27, is a firm fixed-price delivery order contract with a period of performance through December 9, 2024. The contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQVK, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,807.30 firm fixed-price delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The award is not associated with a larger contract vehicle, but Dakota Drug, Inc. does hold a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZSG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract has a ceiling value of $2,476.68 and is a Firm Fixed Price Delivery Order. The contract is for the supply of pharmaceutical products, specifically the drug Trulicity 1.5 mg/0.5 ml pen 0.5 ml, to support U.S. Armed Forces medical operations. This contract is part of the DLA Troop Support Medical's ECAT Generation V Program,...